Delivery Order SPE2DX22D0010-SPE2D826FAQ48

The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,036.80 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on October 26, 2025, with an ultimate completion date of October 27, 2025. This firm fixed-price contract, classified as a non-set-aside competitive award, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.

AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies a comprehensive range of medical products through its federal contracts, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The DLA Troop Support Medical contract vehicle enables the company to deliver pharmaceutical support globally to military healthcare programs and other federal customers, including the Defense Health Agency and U.S. Coast Guard. This delivery order continues AmerisourceBergen's ongoing role as a critical vendor for federal medical procurement needs, leveraging its established relationship as one of the primary pharmaceutical suppliers supporting the Department of Defense's healthcare operations.